Publicaciones en colaboración con investigadores/as de Centro de Investigación Médica Aplicada (18)

2024

  1. Whole exome sequencing and machine learning germline analysis of individuals presenting with extreme phenotypes of high and low risk of developing tobacco-associated lung adenocarcinoma

    eBioMedicine, Vol. 102

2023

  1. Priorities in Cardio-Oncology Basic and Translational Science: GCOS 2023 Symposium Proceedings: JACC: CardioOncology State-of-the-Art Review

    JACC: CardioOncology, Vol. 5, Núm. 6, pp. 715-731

2021

  1. Design and synthesis of water-soluble and potent mmp-13 inhibitors with activity in human osteosarcoma cells

    International Journal of Molecular Sciences, Vol. 22, Núm. 18

  2. Whole exome sequencing characterization of individuals presenting extreme phenotypes of high and low risk of developing tobacco-induced lung adenocarcinoma

    Translational Lung Cancer Research, Vol. 10, Núm. 3, pp. 1327-1337

2019

  1. Identification of mutations associated with acquired resistance to sunitinib in renal cell cancer

    International Journal of Cancer, Vol. 145, Núm. 7, pp. 1991-2001

2018

  1. Genomic characterization of individuals presenting extreme phenotypes of high and low risk to develop tobacco-induced lung cancer

    Cancer Medicine, Vol. 7, Núm. 7, pp. 3474-3483

2017

  1. Stem cell-like transcriptional reprogramming mediates metastatic resistance to mTOR inhibition

    Oncogene, Vol. 36, Núm. 19, pp. 2737-2749

  2. Strategies to design clinical studies to identify predictive biomarkers in cancer research

    Cancer Treatment Reviews, Vol. 53, pp. 79-97

2016

  1. Targeted depletion of PIK3R2 induces regression of lung squamous cell carcinoma

    Oncotarget, Vol. 7, Núm. 51, pp. 85063-85078

  2. Total and mutated EGFR quantification in cell-free DNA from non-small cell lung cancer patients detects tumor heterogeneity and presents prognostic value

    Tumor Biology, Vol. 37, Núm. 10, pp. 13687-13694

  3. Tumor-Produced Interleukin-8 Attracts human myeloid-derived suppressor cells and elicits extrusion of Neutrophil Extracellular Traps (NETs)

    Clinical Cancer Research, Vol. 22, Núm. 15, pp. 3924-3936

2015

  1. Impact of epidermal growth factor receptor (EGFR) activating mutations and their targeted treatment in the prognosis of stage IV non-small cell lung cancer (NSCLC) patients harboring liver metastasis

    Journal of Translational Medicine, Vol. 13, Núm. 1

2013

  1. Safety and efficacy of maintenance therapy with a nonspecific cytochrome P17 inhibitor (CYP17i) after response/stabilization to docetaxel in metastatic castration-resistant prostate cancer

    Clinical Genitourinary Cancer, Vol. 11, Núm. 2, pp. 78-84

2012

  1. Adenosine Deaminase Enhances the Immunogenicity of Human Dendritic Cells from Healthy and HIV-Infected Individuals

    PLoS ONE, Vol. 7, Núm. 12

2010

  1. Increased α-defensins 1-3 production by dendritic cells in HIV-infected individuals is associated with slower disease progression

    PLoS ONE, Vol. 5, Núm. 2

  2. Methylthioadenosine (MTA) inhibits melanoma cell proliferation and in vivo tumor growth

    BMC Cancer, Vol. 10

2009

  1. TWIST1 overexpression is associated with nodal invasion and male sex in primary colorectal cancer

    Annals of Surgical Oncology, Vol. 16, Núm. 1, pp. 78-87

2008

  1. Cdc42 highly expressed in colorectal adecarcinoma and downregulates ID4 through an epigenetic mechanism

    International Journal of Oncology, Vol. 33, Núm. 1, pp. 185-193